Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular melanoma.

Devron H Char1

  • 1The Tumori Foundation, CPMC, Davies Campus, 45 Castro Street, Suite 309, San Francisco, CA 94114, USA. devron@tumori.org

The Surgical Clinics of North America
|May 15, 2003
PubMed
Summary
This summary is machine-generated.

This review covers ocular melanoma, a rare cancer affecting the eye, eyelid, and orbit. Uveal melanoma, the most common type, accounts for 10% of all melanomas and 13% of melanoma deaths.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early genetic evolution of driver mutations in uveal melanoma.

Nature communications·2025
Same author

Early Genetic Evolution of Driver Mutations in Uveal Melanoma.

medRxiv : the preprint server for health sciences·2025
Same author

Long-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam Radiation.

Cancers·2025
Same author

Novel Risk Factors for Uveal Melanoma in Adolescent and Young Adult Patients: A Comprehensive Case-Control Analysis.

Ophthalmology science·2025
Same author

15-Gene Expression Profile and <i>PRAME</i> as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations.

Ophthalmology·2022
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Oncology
  • Molecular Biology

Background:

  • Ocular melanomas are rare cancers affecting various eye structures, including the eyelid, conjunctiva, intraocular tissues, and orbit.
  • Uveal melanoma is the most common primary intraocular malignancy.
  • Uveal melanomas represent approximately 10% of all melanoma diagnoses and contribute to about 13% of melanoma-related mortality.

Purpose of the Study:

  • To provide a comprehensive review of the current understanding of ocular melanomas.
  • To discuss the pathogenesis, molecular alterations, diagnostic approaches, and therapeutic strategies for ocular melanomas.

Main Methods:

  • Literature review of current research on ocular melanomas.
  • Synthesis of information on pathogenesis, molecular changes, diagnosis, and treatment.

Related Experiment Videos

Main Results:

  • Ocular melanomas encompass a spectrum of tumors affecting ocular and orbital structures.
  • Uveal tract melanomas are the most frequent intraocular type.
  • Detailed insights into molecular mechanisms and diagnostic criteria are evolving.

Conclusions:

  • Ocular melanomas require a multidisciplinary approach for effective management.
  • Advances in understanding molecular pathogenesis are paving the way for targeted therapies.
  • Early diagnosis and tailored treatment are crucial for improving patient outcomes in ocular melanoma.